FrancophonIA/ELRC3.0 huggingface dataset:
English: Ebymect 5 mg/850 mg film-coated tablets and Ebymect 5 mg/1,000 mg film-coated tablets are available in PVC/PCTFE/Alu blister.
Danish: Ebymect 5 mg/850 mg filmovertrukne tabletter og Ebymect 5 mg/1000 mg filmovertrukne tabletter er tilgængelige i PVC/PCTFE/Alu-blister.
English: EU/1/15/1051/009 5 mg/1000 mg 56 tablets EU/1/15/1051/010 5 mg/1000 mg 60 tablets EU/1/15/1051/011 5 mg/1000 mg 60 x 1 tablet (unit dose) EU/1/15/1051/012 5 mg/1000 mg 196 (2 x 98) tablets (multipack)
Danish: Ebymect 5 mg/1.000 mg filmovertrukne tabletter EU/1/15/1051/007 5 mg/1.000 mg 14 tabletter EU/1/15/1051/008 5 mg/1.000 mg 28 tabletter EU/1/15/1051/009 5 mg/1.000 mg 56 tabletter EU/1/15/1051/010 5 mg/1.000 mg 60 tabletter EU/1/15/1051/011 5 mg/1.000 mg 60 x 1 tablet (enkeltdosis) EU/1/15/1051/012 5 mg/1.000 mg 196 (2 x 98) tabletter (multipakning)
English: Ebymect must be discontinued prior to, or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable (see sections 4.2 and 4.4).
Danish: Behandling med Ebymect skal afbrydes forud for eller på tidspunktet for billeddiagnostiske procedurer og først genoptages mindst 48 timer herefter, forudsat at nyrefunktionen er blevet vurderet og fundet stabil, se pkt.
English: for available data on different combinations)
Danish: 4.4, 4.5 og 5.1 for tilgængelige data om forskellige kombinationer)
English: • Lactic acidosis, seen very rarely (may affect up to 1 user in 10,000) Ebymect may cause a very rare, but very serious side effect called lactic acidosis (see section “Warnings and precautions”).
Danish: Ebymect kan forårsage en meget sjælden, men meget alvorlig bivirkning, der kaldes laktatacidose (se afsnittet ”Advarsler og forsigtighedsregler”).
English: Ebymect 5 mg/850 mg film-coated tablets
Danish: Ebymect 5 mg/850 mg filmovertrukne tabletter
English: Therapy may be restarted no earlier than 48 hours following surgery or resumption of oral nutrition and provided that renal function has been re-evaluated and found to be stable.
Danish: Behandling med Ebymect skal afbrydes på tidspunktet for kirurgi under generel, spinal eller epidural anæstesi og må tidligst genoptages 48 timer efter kirurgi eller genoptagelse af oral ernæring og under forudsætning af, at nyrefunktionen er blevet vurderet og fundet stabil.
English: In case of dehydration (severe diarrhoea or vomiting, fever or reduced fluid intake), Ebymect should be temporarily discontinued and contact with a health care professional is recommended.
Danish: I tilfælde af dehydrering (alvorlig diarré eller opkastning, feber eller nedsat væskeindtagelse) skal
English: What you need to know before you take Ebymect 3.
Danish: Det skal du vide, før du begynder at tage Ebymect Sådan skal du tage Ebymect Bivirkninger
English: Each Ebymect 5 mg/850 mg film-coated tablet (tablet) contains dapagliflozin propanediol monohydrate equivalent to 5 mg dapagliflozin and 850 mg metformin hydrochloride.
Danish: Hver Ebymect 5 mg/850 mg filmovertrukket tablet (tablet) indeholder dapagliflozinpropandiolmonohydrat svarende til 5 mg dapagliflozin og 850 mg metforminhydrochlorid.
English: Ebymect 5 mg/1,000 mg film-coated tablets
Danish: Ebymect 5 mg/1.000 mg filmovertrukne tabletter
English: In case of suspected symptoms, the patient should stop taking Ebymect and seek immediate medical attention.
Danish: Patienterne skal informeres om at stoppe med at tage metformin og øjeblikkeligt søge lægehjælp ved symptomer, der kan give mistanke om laktatacidose.
English: Ebymect 5 mg/850 mg film-coated tablets Ebymect 5 mg/1,000 mg film-coated tablets
Danish: Ebymect 5 mg/850 mg filmovertrukne tabletter Ebymect 5 mg/1.000 mg filmovertrukne tabletter
English: • Before initiation of treatment and regularly thereafter (see sections 4.2, 4.8, 5.1 and 5.2).
Danish: • Inden behandlingsstart og regelmæssigt derefter (se pkt.
English: Each Ebymect 5 mg/1,000 mg film-coated tablet (tablet) contains dapagliflozin propanediol monohydrate equivalent to 5 mg dapagliflozin and 1,000 mg metformin hydrochloride.
Danish: Hver Ebymect 5 mg/1000 mg filmovertrukket tablet (tablet) indeholder dapagliflozinpropandiolmonohydrat svarende til 5 mg dapagliflozin og 1000 mg metforminhydrochlorid.
English: Ebymect 5 mg/850 mg tablets dapagliflozin/metformin HCl
Danish: Ebymect 5 mg/850 mg tabletter dapagliflozin/metformin HCl
English: Ebymect 5 mg/1,000 mg tablets dapagliflozin/metformin HCl
Danish: Ebymect 5 mg/1000 mg tabletter dapagliflozin/metformin HCl
English: Ebymect has been demonstrated to be bioequivalent with coadministered dapagliflozin and metformin (see section 5.2).
Danish: Der er påvist bioækvivalens mellem Ebymect og samtidig administration af dapagliflozin og metformin (se pkt.
English: Ebymect 5 mg/850 mg film-coated tablets Ebymect 5 mg/1,000 mg film-coated tablets dapagliflozin/metformin hydrochloride
Danish: Ebymect 5 mg/850 mg filmovertrukne tabletter Ebymect 5 mg/1000 mg filmovertrukne tabletter dapagliflozin/metforminhydrochlorid
English: • a significant reduction of the absolute risk of any diabetes-related mortality: metformin 7.5 events/1,000 patient-years, diet alone 12.7 events/1,000 patient-years, p=0.017;
Danish: 7,5 hændelser/1000 patientår, diæt alene 12,7 hændelser/1000 patientår, p=0,017;
English: • a significant reduction of the absolute risk of any diabetes-related complication in the metformin group (29.8 events/1,000 patient-years) versus diet alone (43.3 events/1,000 patient-years), p=0.0023, and versus the combined sulphonylurea and insulin monotherapy groups (40.1 events/1,000 patient-years), p=0.0034;
Danish: (43,3 hændelser/1000 patientår), p=0,0023, og versus den kombinerede gruppe af sulfonylurinstoffer og insulin-monoterapigruppen (40,1 hændelser/1000 patientår), p=0,0034;
English: Ebymect 5 mg/1,000 mg film-coated tablets dapagliflozin/metformin hydrochloride
Danish: Ebymect 5 mg/1000 mg filmovertrukne tabletter dapagliflozin/metforminhydrochlorid
English: Ebymect 5 mg/850 mg film-coated tablets dapagliflozin/metformin hydrochloride
Danish: Ebymect 5 mg/850 mg filmovertrukne tabletter dapagliflozin/metforminhydrochlorid
English: Ελλάδα
Danish: Lør.
English: deficiency h,§
Danish: Vitamin B12mangel h,§
English: If you take more Ebymect than you should
Danish: Hvis du har taget for meget Ebymect
English: Uncommon (may affect up to 1 in 100 people) • thirst
Danish: Ikke almindelig (kan forekomme hos op til 1 ud af 100 personer)
English: The marketing authorisation was renewed on 9 March 2005.
Danish: Markedsføringstilladelsen blev fornyet den 9. marts 2005.
English: suicidal thoughts or suicide attempts.
Danish: selvmordstanker eller selvmordsforsøg.
English: These contain from 1 to 50 million IU (international units) per millilitre.
Danish: Disse indeholder fra 1 til 50 mio. IE (internationale enheder) pr. milliliter.
English: The European Commission granted a marketing authorisation valid throughout the EU for Viraferon to SP Europe on 9 March 2000.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Viraferon til SP Europe den 9. marts 2000.
English: Viraferon has to be stored in a refrigerator (2°C-8°C).
Danish: Viraferon skal opbevares i køleskab (2°C - 8°C).
English: Because Viraferon can be associated with side effects such as depression, patients must be closely monitored during treatment.
Danish: Da Viraferon kan forbindes med bivirkninger såsom depression, skal patienterne overvåges nøje under behandlingen.
English: The most common side effects with Viraferon in adults (seen in more than 1 patient in 10) are leucopenia (low white blood cell counts), anorexia (loss of appetite), depression, insomnia (difficulty sleeping), anxiety, agitation, nervousness, dizziness, headache, impaired concentration, dry mouth, blurred vision, nausea (feeling sick) or vomiting, abdominal (tummy) pain, diarrhoea, stomatitis (inflammation of the lining of the mouth), dyspepsia (indigestion), alopecia (hair loss), increased sweating, myalgia (muscle pain), arthralgia (joint pain), musculoskeletal pain (pain in the muscles and bones), inflammation at the site of the injection, fatigue (tiredness), rigors (shaking chills), fever, flulike symptoms, asthenia (weakness), irritability, chest pain, malaise (feeling unwell) and weight loss.
Danish: De hyppigste bivirkninger i forbindelse med Viraferon (indberettet hos flere end 1 ud af 10 patienter) er leukopeni (lavt antal hvide blodlegemer), appetitløshed, depression, søvnløshed, angst, ophidselse, nervøsitet, svimmelhed, hovedpine, nedsat koncentrationsevne, mundtørhed, sløret syn, kvalme eller opkastning mavesmerter, diarré, betændelse i mundslimhinden (stomatitis), dyspepsi (fordøjelsesbesvær), hårtab, øget svedafsondring, muskelsmerter, ledsmerter, smerter i muskler og knogler, betændelse på indstiksstedet, træthed, kulderystelser, feber, influenzalignende symptomer, slaphed, irritabilitet, brystsmerter, ubehag og vægttab.
English: Interferons are natural substances produced by the body to help it fight against attacks such as infections caused by viruses.
Danish: Interferoner er naturlige stoffer, der produceres af kroppen, og som hjælper med til at bekæmpe angreb mod kroppen såsom infektioner, der skyldes vira.
English: Other information about Viraferon:
Danish: Andre oplysninger om Viraferon:
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) VIRAFERON EPAR summary for the public
Danish: EUROPÆISK OFFENTLIG VURDERINGSRAPPORT (EPAR) VIRAFERON EPAR - sammendrag for offentligheden
English: The exact way alpha interferons work in viral diseases is not fully understood, but it is thought that they act as immunomodulators (substances that modify how the immune system, the body's defence system, works).
Danish: Den nøjagtige måde, hvorpå alfa-interferoner virker mod kræftog virussygdomme kendes endnu ikke fuldt ud, men man mener, at de virker som immunmodulatorer (stoffer der ændrer den måde, hvorpå immunsystemet (kroppens forsvarssystem) fungerer).
English: in adults;
Danish: hos voksne,
English: The full EPAR for Viraferon is available here.
Danish: Den fuldstændige EPAR om Viraferon findes her.
English: • children and adolescents with a history of severe mental illness, particularly severe depression,
Danish: • Børn og unge med en sygehistorie, der omfatter alvorlig mental sygdom, især svær depression,
English: Viraferon should not be used in:
Danish: Viraferon bør ikke anvendes af:
English: Viraferon is used for the treatment of:
Danish: Viraferon anvendes til behandling af:
English: It was also effective in children when used with ribavirin, with 46% of the children having responded to treatment at the six-month follow up visit following a year's treatment.
Danish: Det var ligeledes effektivt til børn, når det blev anvendt sammen med ribavirin, idet 46 % af børnene havde reageret positivt på behandlingen ved det 6-måneders kontrolbesøg, der fulgte efter 1 års behandling.
English: The studies showed that Viraferon is effective in the diseases for which it can be used.
Danish: Undersøgelserne viste, at Viraferon er effektivt til behandling af de sygdomme, til hvilke det er indikeret.
English: Treatment with Viraferon should be initiated by a doctor who has experience in the management of the disease it is being used for.
Danish: Behandlingen med Viraferon bør varetages af en læge med erfaring i behandling af den sygdom, lægemidlet anvendes til.
English: • patients with epilepsy or other central nervous system problems,
Danish: • Patienter med epilepsi eller andre problemer i centralnervesystemet,
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Viraferon's benefits are greater than its risks for the treatment of chronic hepatitis B and C. The Committee recommended that Viraferon be given marketing authorisation.
Danish: Udvalget for Humanmedicinske Lægemidler (CHMP) var af den opfattelse, at fordelene ved Viraferon opvejer risiciene ved behandling af kronisk hepatitis B og C. Udvalget anbefalede udstedelse af markedsføringstilladelse for Viraferon.
English: The use of Viraferon in combination with ribavirin has also been studied in 118 hepatitis C treatment-naïve children aged between three and 16 years.
Danish: Brugen af Viraferon i kombination med ribavirin er endvidere blevet undersøgt hos 118 behandlingsnaive børn med hepatitis C i alderen 3-16 år.
English: Alpha interferons may also block the multiplication of viruses.
Danish: Alfainterferoner kan ligeledes blokere formeringen af vira.
English: Similar side effects have been seen in children receiving Viraferon, as well as inhibition of growth.
Danish: Der kunne iagttages tilsvarende bivirkninger hos børn, der fik Viraferon , samt hæmning af vækst.
English: Because interferon alfa-2b has been used to treat a number of diseases in the European Union (EU) before, the company that makes Viraferon supplied data from the scientific literature and from studies of its use in children with chronic hepatitis B. The company also supplied information from a number of studies of Viraferon used alone or with ribavirin for the treatment of chronic hepatitis C. These included a total of 2,552 treatment-naïve patients (who had not been treated before) and a total of 345 patients whose disease had relapsed (returned) after previous treatment with interferon.
Danish: Da interferon alfa-2b tidligere er blevet anvendt til behandling af en række sygdomme i EU, har firmaet, der fremstiller Viraferon, fremlagt data fra den videnskabelige litteratur og fra undersøgelser af brugen af interferon alfa-2b til børn med kronisk hepatitis B. Virksomheden fremlagde ligeledes resultater fra en række undersøgelser, hvor Viraferon blev anvendt alene eller sammen med ribavirin til behandling af kronisk hepatitis C. Disse undersøgelser omfattede i alt 2 552 behandlingsnaive patienter (som ikke var blevet behandlet tidligere) og i alt 345 patienter, hvis sygdom var vendt tilbage efter tidligere behandling med interferon.
English: It is available as a powder and solvent to be made up into a solution for injection or infusion, as a ready-to-use solution for injection and as a multidose pen for injection.
Danish: Det leveres som pulver og solvens, der skal blandes til en injektionsvæske eller infusionsvæske, opløsning, som en brugsklar injektionsvæske, opløsning, og som en multidosis injektionspen.
English: The interferon alfa-2b in Viraferon is produced by a method known as ‘recombinant DNA technology': the interferon alfa-2b is made by a bacterium that has received a gene (DNA), which makes it able to produce it.
Danish: Interferon alfa-2b i Viraferon produceres ved en metode, der kaldes ‘rekombinant DNA-teknologi': interferon alfa-2b produceres af en bakterie, der har modtaget et gen (DNA), som sætter bakterien i stand til at producere stoffet.
English: • patients with severe kidney or liver disease including that caused by cancer,
Danish: • Patienter med alvorlig nyre- eller leversygdom, herunder en sådan, der er forårsaget af kræft,
English: • patients with thyroid disease unless it is controlled,
Danish: • Patienter med skjoldbrusksygdom, medmindre den er under kontrol,
English: • patients with a history of certain disorders of the immune system, or who have had an organ transplant and are taking medicines that suppress the immune system,
Danish: • Patienter med en sygehistorie med visse forstyrrelser i immunsystemet, eller som har gennemgået organtransplantation, og som tager medicin, der svækker immunsystemet,
English: Viraferon is a medicine containing the active substance interferon alfa-2b.
Danish: Viraferon er et lægemiddel, der indeholder det aktive stof interferon alfa-2b.
English: Viraferon should not be used in people who may be hypersensitive (allergic) to interferon alfa-2b or any of the other ingredients.
Danish: Viraferon bør ikke anvendes af personer, som kan være overfølsomme (allergiske) over for interferon alfa-2b eller et af de øvrige indholdsstoffer.
English: • chronic (long-term) hepatitis B (a disease of the liver due to an infection by the hepatitis B virus)
Danish: • kronisk (langvarig) hepatitis B (en leversygdom, der skyldes en infektion med hepatitis B-virus)
English: The main measure of effectiveness was response rates.
Danish: Virkningen blev hovedsagelig bedømt på responsraten.
English: • chronic hepatitis C (a disease of the liver due to an infection by the hepatitis C virus).
Danish: • kronisk hepatitis C (en leversygdom, der skyldes en infektion med hepatitis C-virus).
English: Viraferon was also shown to have a benefit in children with chronic hepatitis B. Viraferon, with or without ribavirin, was shown to be effective in treating hepatitis C in both treatment-naïve and relapsed adults.
Danish: Viraferon har også vist sig at være fordelagtig til børn med kronisk hepatitis B. Viraferon, sammen med eller uden ribavirin, viste sig at være effektiv til behandling af hepatitis C hos både behandlingsnaive voksne og hos voksne, hvis sygdom var vendt tilbage.
English: The active substance in Viraferon, interferon alfa-2b, belongs to the group ‘interferons'.
Danish: Det aktive stof i Viraferon, interferon alfa-2b, hører til gruppen af ‘interferoner'.
English: Viraferon can be used on its own but is best used in combination with ribavirin (an antiviral medicine).
Danish: Hos voksne kan Viraferon anvendes alene, men det er bedst at anvende det i kombination med ribavirin (et antiviralt lægemiddel) Hos børn anvendes det sammen med ribavirin.
English: What is the risk associated with Viraferon?
Danish: Hvilken risiko er der forbundet med Viraferon?
English: Viraferon is given three times per week (every other day) by subcutaneous injection (under the skin).
Danish: Viraferon gives normalt tre gange om ugen (hver anden dag).
English: Why has Viraferon been approved?
Danish: Hvorfor blev Viraferon godkendt?
English: What is Viraferon?
Danish: Hvad er Viraferon?
English: • hepatitis patients who have liver cirrhosis (scarring) that is causing symptoms or who have recently received medicines that affect the immune system,
Danish: • Hepatitis-patienter med levercirrose eller som for nylig er blevet behandlet med lægemidler, der påvirker immunsystemet,
English: For the full list of all side effects reported with Viraferon, see the Package Leaflet.
Danish: Den fuldstændige liste over de indberettede bivirkninger ved Viraferon fremgår af indlægssedlen.
English: For a list of all restrictions with Viraferon, see the Package Leaflet.
Danish: Den fuldstændige liste over begrænsninger i forbindelse med Viraferon fremgår af indlægssedlen.
English: The dose and duration of treatment depend on the disease being treated and the response of the patient, with doses ranging from 3 to 10 million IU per square metre of body surface area.
Danish: Doserne ligger i området fra 3 til 10 millioner IE pr. kvadratmeter legemsoverflade.
English: • patients with a history of severe heart disease,
Danish: • Patienter med alvorlig hjertesygdom,
English: How has Viraferon been studied?
Danish: Hvordan blev Viraferon undersøgt?
English: What benefit has Viraferon shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Viraferon?
English: What is Viraferon used for?
Danish: Hvad anvendes Viraferon til?
English: How is Viraferon used?
Danish: Hvordan anvendes Viraferon?
English: How does Viraferon work?
Danish: Hvordan virker Viraferon?
English: • Not drink Grapefruit Juice
Danish: • Undlade at drikke grapefrugtjuice
English: • A dose reduction of Ranexa may be needed in combination with:
Danish: • En dosisreduktion af Ranexa kan være nødvendig i kombination med:
English: • With certain other risk factors listed in the product information
Danish: • Med visse andre risikofaktorer som anført i produktinformationen
English: The PAC must include the following key messages:
Danish: Alarmkortet skal indeholde følgende vigtige meddelelser:
English: • That the card should be shown to any doctor involved in their treatment
Danish: • Kortet skal vises til alle læger, der er involveret i patientens behandling
English: • Have ever had an abnormal electrocardiogram (ECG)
Danish: • Tidligere anormalt elektrokardiogram (EKG)
English: • Is taking allergy medicines
Danish: • Patienten tager lægemidler mod allergi
English: • Liver problems
Danish: • Leverproblemer
English: • Taking certain other drugs mentioned in the product information
Danish: • Der tager visse andre lægemidler, der er nævnt i produktinformationen
English: • Call their doctor if they feel dizzy or sick, become sick or experience any unexpected symptoms after starting Ranexa.
Danish: • Kontakte sin læge, hvis han/hun føler sig svimmel eller får kvalme, kaster op eller får et eller flere uventede symptomer efter at have påbegyndt behandlingen med Ranexa.
English: • Ranexa is contraindicated in patients taking:
Danish: • Ranexa er kontraindiceret til patienter, der tager:
English: • To refer to the Ranexa SPC prior to prescribing any medications to the patient, as there are potential drug interactions which should be taken into consideration.
Danish: • Produktresuméet for Ranexa skal læses, inden der ordineres nogen lægemidler til patienten, da der kan forekomme lægemiddelinteraktioner, som det er nødvendigt at tage hensyn til.
English: • Is taking medications to treat epilepsy, bacterial or fungal infections, HIV infection, depression or heart rhythm disorders
Danish: • Patienten tager lægemidler mod epilepsi, bakterielle infektioner eller svampeinfektioner, HIVinfektion, depression eller hjerterytmelidelser
English: Patient information The PAC should include the following information for the patient:
Danish: Oplysninger til patienten Alarmkortet skal indeholde følgende oplysninger til patienten:
English: • Inform the patient about the potential for an interaction with other prescribed medicinal products and to contact his/her doctor in case of dizziness, nausea or vomiting.
Danish: • Patienten skal informeres om risikoen for interaktion med andre ordinerede lægemidler og have besked på at søge læge, hvis han/hun bliver svimmel, får kvalme eller kaster op.
English: Health Care Professional information The PAC should include the following information for the healthcare professional information regarding Ranexa:
Danish: Oplysninger til læger og sundhedspersonale Alarmkortet skal indeholde følgende oplysninger til læger og sundhedspersonale vedrørende Ranexa:
English: • Caution should be exercised when prescribing Ranexa to patients:
Danish: • Der skal udvises forsigtighed, når Ranexa ordineres til patienter:
English: • That during treatment with Ranexa the patient should:
Danish: • Under behandlingen med Ranexa skal patienten:
English: The Pharmacist should be requested to distribute a PAC to each patient at the time Ranexa is dispensed.
Danish: Apoteket skal have besked på at udlevere et alarmkort til hver enkelt patient, når Ranexa udleveres.
English: • Moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin, fluconazole)
Danish: • Moderate CYP3A4-hæmmere (f.eks. diltiazem, erythromycin, fluconazol)
English: • Potent CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, voriconazol, posaconazol, HIV protease inhibitors, clarithromycin, telithromycin, nefazodone)
Danish: • Potente CYP3A4-hæmmere (f.eks. itraconazol, ketoconazol, voriconazol, posaconazol, HIVHIVproteasehæmmere)
English: • Class Ia (e.g. quinidine) or Class III (e.g. dofetilide, sotalol) antiarrhythmics other than Amiodarone
Danish: • clarithromycin, telithromycin, nefazodon) Antiarytmika af klasse Ia (f.eks. quinidin), eller klasse III (f.eks. dofetilid og sotalol), bortset fra amiodaron
English: • To ensure to take a list of all their other medicines with them at any visit to the health care professional.
Danish: • Patienten skal altid have en liste over al den medicin, han/hun tager, med ved alle besøg hos lægen.
English: CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
Danish: Medlemsstaterne skal sikre, at alle betingelser eller begrænsninger med hensyn til en sikker og effektiv anvendelse af lægemidlet som beskrevet nedenfor er implementeret: 1.
English: • P-gp inhibitors (e.g. ciclosporin, verapamil)
Danish: • PP-gp-hæmmere (f.eks. ciclosporin, verapamil)